Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SAMD1 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | CALU | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-07 |
mRNA | LUC7L | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | RIOK1 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | SUPT16H | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | ATF4 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | SET | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | EEF1B2 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
mRNA | WDR33 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
mRNA | LRP1 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |